blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4218823

EP4218823 - NOVEL POLYMERIC HGH PRODRUGS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  17.05.2024
Database last updated on 19.07.2024
FormerThe application has been published
Status updated on  30.06.2023
Most recent event   Tooltip17.05.2024The date on which the examining division becomes responsible, has been established 
17.05.2024Request for examination filedpublished on 19.06.2024  [2024/25]
17.05.2024Change - designated statespublished on 19.06.2024  [2024/25]
Applicant(s)For all designated states
ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S
Tuborg Boulevard 12
2900 Hellerup / DK
[2023/31]
Inventor(s)01 / Kurpiers, Thomas
69120 Heidelberg / DE
02 / Rau, Harald
69120 Heidelberg / DE
03 / Exner, Evelyn
69120 Heidelberg / DE
04 / Jensen, Steen
2900 Hellerup / DK
05 / Rasmussen, Grethe Nørskov
2900 Hellerup / DK
06 / Lessmann, Torben
69120 Heidelberg / DE
07 / Wegge, Thomas
69120 Heidelberg / DE
08 / Hermann, Alina
69120 Heidelberg / DE
09 / Schubert, Nina
69120 Heidelberg / DE
10 / Splanemann, Anna
69120 Heidelberg / DE
11 / Zettler, Joachim
69120 Heidelberg / DE
 [2023/31]
Representative(s)Büchel, Edwin
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[2023/31]
Application number, filing date23164305.717.11.2015
[2023/31]
Priority number, dateEP2014019360318.11.2014         Original published format: EP 14193603
[2023/31]
Previously filed application, dateEP2015079764217.11.2015
[2023/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4218823
Date:02.08.2023
Language:EN
[2023/31]
Type: A3 Search report 
No.:EP4218823
Date:15.11.2023
Language:EN
[2023/46]
Search report(s)(Supplementary) European search report - dispatched on:EP16.10.2023
ClassificationIPC:A61K47/60, A61P43/00, A61K38/27, A01G17/00, A01G2/00, A61P5/06, A61P13/12
[2023/32]
CPC:
A61K38/27 (EP,IL,KR,US); A61K47/60 (EP,IL,KR,RU,US); A01G17/005 (EP,CN,IL);
A01G2/00 (EP,IL); A01G7/06 (CN,IL); A61K47/12 (IL,KR,US);
A61K47/20 (IL,KR,US); A61K47/26 (IL,KR,US); A61K9/0019 (IL);
A61K9/08 (IL,KR,US); A61K9/19 (IL,KR); A61P13/12 (EP,IL,RU);
A61P43/00 (EP,IL); A61P5/06 (EP,IL,KR,RU); C07K14/61 (IL,RU);
C08G65/3348 (IL,US); C08G2650/06 (IL,US) (-)
Former IPC [2023/31]A61K47/50, A61P43/00, A61K38/27, A61K47/60, A61P13/12, A61P5/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/25]
Former [2023/31]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:NEUARTIGE POLYMERE HGH-PRODRUGS[2023/31]
English:NOVEL POLYMERIC HGH PRODRUGS[2023/31]
French:NOUVEAUX PROMÉDICAMENTS À BASE D'HORMONE DE CROISSANCE HUMAINE (HGH) POLYMÈRE[2023/31]
Examination procedure13.05.2024Amendment by applicant (claims and/or description)
13.05.2024Examination requested  [2024/25]
13.05.2024Date on which the examining division has become responsible
Parent application(s)   TooltipEP15797642.4  / EP3237014
Fees paidRenewal fee
27.03.2023Renewal fee patent year 03
27.03.2023Renewal fee patent year 04
27.03.2023Renewal fee patent year 05
27.03.2023Renewal fee patent year 06
27.03.2023Renewal fee patent year 07
27.03.2023Renewal fee patent year 08
29.11.2023Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP1579873  (COMPLEX BIOSYSTEMS GMBH [DE]) [Y] 1-16 * the whole document * * paragraphs [0040] , [0042]; claim - *;
 [Y]WO2005099768  (COMPLEX BIOSYSTEMS GMBH [DE], et al) [Y] 1-16 * the whole document * * example -; claim - *;
 [Y]EP1625855  (COMPLEX BIOSYSTEMS GMBH [DE]) [Y] 1-16 * the whole document * * paragraphs [0042] , [0044]; claim - *;
 [A]WO2006102659  (NEKTAR THERAPEUTICS AL CORP [US], et al) [A] 1-16* the whole document *;
 [XDY]EP2113256  (ASCENDIS PHARMA AS [DK]) [XD] 1,5,10,11,13,14,16 * the whole document * * paragraphs [0083] - [0089]; claim - * [Y] 1-16;
 [XDY]WO2009133137  (ASCENDIS PHARMA AS [DK], et al) [XD] 1-5,10,11,13,14,16 * the whole document * * pages 23-28; example -; claim - * [Y] 1-16
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.